C12Y 304/14004
Dipeptidyl-peptidase iii
Official title: Dipeptidyl-peptidase III (3.4.14.4)
C12Y304/14004 (Dipeptidyl-peptidase iii) appears on 0 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 5
- Assignees
- 4
- Inventors
- 11
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
No granted patents in this class yet.
- Prediction of an increase of dpp3 in a patient with septic shock29 Jan 2026US 2026/0028423 A14TEEN4 Pharmaceuticals GmbH
- Elimination of aflatoxin via aflatoxin-degrading enzyme expression in crops5 Sep 2024US 2024/0294932 A1Arizona Board of Regents on Behalf of the University of Arizona
- Modified cleavases, uses thereof and related kits17 Aug 2023US 2023/0257727 A1Encodia, Inc.
- Therapy guidance and/or therapy monitoring for a treatment with angiotensin-receptor-agonist and/or a precursor thereof7 Jul 2022US 2022/0211798 A14TEEN4 Pharmaceuticals GmbH
- Site-specific mutagenesis modified yeast dipeptidyl peptidase iii15 Aug 2019US 2019/0246664 A1Guangdong Genuizymes Animal Health Co., Ltd
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.